2020
DOI: 10.1097/j.pain.0000000000002111
|View full text |Cite
|
Sign up to set email alerts
|

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 26 publications
(24 citation statements)
references
References 158 publications
(62 reference statements)
1
22
0
1
Order By: Relevance
“…Although there is an overlap between DLB and Parkinson's disease dementia (PDD), with some clinicians placing them on the same disease continuum, current consensus diagnostic criteria categorize them as two specific disorders based on the temporal onset of dementia relative to parkinsonism: dementia occurring within the first year following the onset of parkinsonism is diagnosed as DLB [96,97]. Here, we focus primarily on DLB, as pain in Parkinson's has been reviewed elsewhere [1,2,98,99].…”
Section: Pain In Dementia With Lewy Bodiesmentioning
confidence: 99%
“…Although there is an overlap between DLB and Parkinson's disease dementia (PDD), with some clinicians placing them on the same disease continuum, current consensus diagnostic criteria categorize them as two specific disorders based on the temporal onset of dementia relative to parkinsonism: dementia occurring within the first year following the onset of parkinsonism is diagnosed as DLB [96,97]. Here, we focus primarily on DLB, as pain in Parkinson's has been reviewed elsewhere [1,2,98,99].…”
Section: Pain In Dementia With Lewy Bodiesmentioning
confidence: 99%
“…Chronic pain, present in over 80% People with Parkinson's disease (PD, PwP), is a challenging non-motor symptom (NMS), adversely affecting the health-related quality of life. [1][2][3] In individuals from ethnic minorities, a distinctive non-motor dominant clinical phenotype of PD, marked by a greater NMS burden, including heightened pain experience, has been reported. 4 Disparities in diagnosis, treatment and survival of PwP from ethnic minorities, compared to White PD patients, exist.…”
Section: Resultsmentioning
confidence: 99%
“…Conclusions Conclusions: Ethnic disparities in the analgesic use among PwP with chronic pain living in the UK are evident in this retrospective analysis, prompting large-scale studies and reinforcement of interventions to tackle the impact ethnicity might have on the successful analgesia.Chronic pain, present in over 80% People with Parkinson's disease (PD, PwP), is a challenging non-motor symptom (NMS), adversely affecting the health-related quality of life. [1][2][3] In individuals from ethnic minorities, a distinctive non-motor dominant clinical phenotype of PD, marked by a greater NMS burden, including heightened pain experience, has been reported. 4 Disparities in diagnosis, treatment and survival of PwP from ethnic minorities, compared to White PD patients, exist.…”
mentioning
confidence: 99%
“…Studies formally characterizing sensory function in different Alzheimer’s disease mouse models are not abundant (Reviewed by Lawn et al, 2021 ). In our hands, sensory evaluations did not yield a distinct functional difference between 5XFAD and wild-type animals.…”
Section: Discussionmentioning
confidence: 99%